Alexion Pharmaceuticals reported $27.1M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Amgen AMGN:US $ 281M 4M
Biogen BIIB:US $ 56.4M 8.3M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Bristol Myers Squibb BMY:US $ 330M 23M
Eli Lilly And LLY:US $ 86.9M 0.9M
Esperion Therapeutics ESPR:US $ 11.14M 3.02M
Gilead Sciences GILD:US $ 256M 1M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Insmed INSM:US $ 10.32M 2.76M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Johnson & Johnson JNJ:US $ 40M 23M
Moderna Inc MRNA:US 5M 2M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Novartis NOVN:VX 201M 1000K
Omeros OMER:US $ 4.91M 13K
Pfizer PFE:US $ 316M 20M
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Puma Biotechnology PBYI:US $ 3.52M 0.07M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
United Therapeutics UTHR:US $ 4.7M 0.1M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M